The following is a summary of "Heme-induced lung injury in human precision-cut lung slices: a new model for acute lung injury ...

Researchers use biocompatible polydopamine nanoparticles and near-infrared light to remotely trigger activity in neuron and ...

Incyte today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from ...

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

In a landmark move, the FDA recently announced plans to phase out the requirement for animal testing in drug development, encouraging the use of human-relevant, in silico methods instead. This shift ...

Crown BioScience experts explore how 3D in vitro assays mimic the suppressive tumor microenvironment to improve drug response ...

Ligand Pharmaceuticals offers biotech exposure with reduced risk through its royalty platform. Discover why its valuation now ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector ...

The start of the new fiscal is witnessing a tariff-riddled world and an unprecedented churn in the markets globally. Against ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system ...